Location
Sutton (Greater London)
Department
Cancer Therapeutics
Advertising Salary
Competitive Starting Salary
Vacancy Type
Permanent
External Advertising End Date
11 Sep 2022

Key Information

Competitive Starting Salary

This role is eligible for ICR Sponsorship.  Support will be provided for costs associated with Visa application and health surcharge

Hours per week: 35 hours per week (Full Time)

The ICR has engaged Perrett Laver to support the Appointment Panel for this role. Further information regarding this role and the candidate specification can be found on their website at candidates.perrettlaver.com/vacancies/3085/team_leader_in_in_vivo_biology/ or by clicking the ‘Job Description Pack’ button on this page.

For further discussion regarding the role, please contact Dr Goran Gregorovic on +44 (0)77 3268 8855 or [email protected]

Should you require access to these documents in alternative formats, please contact Lina Franzen on [email protected]

Please DO NOT USE the apply now button on this page; all applications are requested to go through Perret Laver.

Closing Date9am (BST) on Monday 12th September 2022 on Perrett Laver site. Final stage interviews will take place in late 2022.

 We reserve the right to close this vacancy early if we receive sufficient applications for the role. Therefore, if you are interested, please submit your application as early as possible

Job Details

Summary of Role

The ICR is now seeking a leading cancer biologist with a track record of success to lead the in vivo biology to support the drug discovery activities of the CTU.  The successful applicant will have the necessary scientific background and experience to hold the appropriate UK Home Office Project Licences. In addition, as a faculty member in the Division of Cancer Therapeutics, they will lead an independent cancer biology research group that will contribute to the overall strategy and goals of the Division and the CTU. As appropriate, the appointee will assume a leadership role for one or more drug discovery projects within the CTU portfolio.

Key Requirements

The successful candidate will have extensive experience with a range of in vivo models (e.g. syngeneic, xenograft, orthotopic and metastatic tumours, patient-derived xenografts, genetically engineered animals), and will bring a strong vision for the future evolution of in vivo models. The appointee will be committed to translational and drug discovery research in the preclinical setting. Experience of drug discovery in a pharma or biotechnology company is desirable.

 

Department/Directorate Information:

The Division of Cancer Therapeutics has an unrivalled track record at discovering novel cancer treatments for the personalised treatment of cancer. The Division houses the Cancer Therapeutics Unit (CTU), one of the largest academic cancer drug discovery groups in the world. With our collaborators, the CTU has discovered 20 preclinical development candidates since 2005, 12 of which have been progressed to clinical evaluation. Our drug abiraterone (Zytiga) has been approved in the US, Canada, and Europe for late-stage prostate cancer.

The ICR has engaged Perrett Laver to support the Appointment Panel for this role and further information can be downloaded from their website at candidates.perrettlaver.com/vacancies using reference number 5476.

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

 

We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.

Other jobs like this

Location
Sutton (Greater London)
Department
Cancer Therapeutics
Advertising Salary
Competitive Starting Salary
Vacancy Type
Permanent
External Advertising End Date
11 Sep 2022
Location
Chelsea (London)
Department
Breast Cancer
Advertising Salary
Salary Range £43,000 - £56,000 per annum
Vacancy Type
Fixed term
External Advertising End Date
18 Sep 2022
Location
Sutton (Greater London)
Department
Digital Services
Advertising Salary
Salary Range £45,000 - £50,000 (inclusive of market rate supplement)
Vacancy Type
Permanent
External Advertising End Date
11 Sep 2022